The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus — DISCLUP2008  

Discoid Lupus Erythematosus (DLE) Clinical Trial

Official title: A Phase 2 Open Label Study to Assess the Efficacy and Safety of Etanercept (Enbrel®)for the Treatment of Discoid Lupus Erythematosus

Status Recruiting

Clinical Trial Summary

A 20 week study to assess the safety and efficacy of etanercept(Enbrel®)for the treatment of Discoid Lupus Erythematosus

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Discoid Lupus Erythematosus (DLE)
• Lupus Erythematosus, Discoid
• Lupus Erythematosus, Systemic

• NCT number: NCT00797784
• Study type: Interventional
• Source: Florida Academic Dermatology Centers
• Contact: Annika M Grant, RN, MBA
• Phone: 305 324 2110
• Email: annika@fadcenter.com
• Status: Recruiting
• Phase: Phase 2
• Start date: October 2008
• Completion date: April 2011